Furthermore, Stat3 antisense gene therapy leads to increased tumour apoptosis in vivo, which is associated with decreased Bcl-XL protein expression (Grandis et al, 2000; Song and Grandis, 2000; Kijima et al, 2002). This evidence concerns the gene STAT3 and neoplasm.